Full Text Journal Articles by
Author James W F Catto

Advertisement

Find full text journal articles






The European Urology Commitment to Gender Equity and Diversity: Expanding Cognitive Diversity through Inclusivity at the Podium.

Sarah P Psutka, Todd Morgan, Maarten Albersen, Jean-Nicolas Cornu, Giacomo Novara, Elizabeth Plimack, Piet Ost, James W F Catto,

Eur Urol (European urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review.

Logan G Briggs, Chanan Reitblat, Paul A Bain, Sara Parke, Ny-Ying Lam, Jonathan Wright, James W F Catto, Robert J Copeland, Sarah P Psutka,

<h4>Context</h4>The Consensus on Therapeutic Exercise Training (CONTENT) scale assesses the therapeutic validity of exercise programs. To date, prehabilitation exercise programs for heath optimization before urologic cancer surgeries have not been assessed for therapeutic validity or efficacy.<h4>Objective</h4>To systematically assess prehabilitation exercise programs before urologic cancer surgery for therapeutic validity and efficacy, ... Read more >>

Eur Urol (European urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?

Richard T Bryan, James W F Catto, Kieran P Jefferson, Prashant Patel, Nicholas D James, On Behalf Of The BladderPath Trial Management Group,

Eur Urol (European urology)
[2021, 80(1):18-19]

Cited: 1 time

View full text PDF listing >>



Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.

Richard T Bryan, Wenyu Liu, Sarah J Pirrie, Rashid Amir, Jean Gallagher, Ana I Hughes, Kieran P Jefferson, Allen Knight, Veronica Nanton, Harriet P Mintz, Ann M Pope, James W F Catto, Prashant Patel, Nicholas D James,

Transurethral resection of bladder tumour (TURBT) is central to the diagnosis of muscle-invasive bladder cancer (MIBC). With the oncological safety of TURBT unknown, staging inaccuracies commonplace, and correct treatment of MIBC potentially delayed, multiparametric magnetic resonance imaging (mpMRI) may offer rapid, accurate, and noninvasive diagnosis of MIBC. BladderPath is a ... Read more >>

Eur Urol (European urology)
[2021, 80(1):12-15]

Cited: 0 times

View full text PDF listing >>



Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.

James W F Catto, Amy Downing, Samantha Mason, Penny Wright, Kate Absolom, Sarah Bottomley, Luke Hounsome, Syed Hussain, Mohini Varughese, Caroline Raw, Phil Kelly, Adam W Glaser,

<h4>Background</h4>Little is known about health-related quality of life (HRQOL) following treatment for bladder cancer (BC).<h4>Objective</h4>To determine this, we undertook a cross-sectional survey covering 10% of the English population.<h4>Design, setting, and participants</h4>Participants 1-10 yr from diagnosis were identified through national cancer registration data.<h4>Intervention</h4>A postal survey was administered containing generic HRQOL and BC-specific ... Read more >>

Eur Urol (European urology)
[2021, 79(5):621-632]

Cited: 1 time

View full text PDF listing >>



Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).

Simon J Crabb, Sarah Danson, James W F Catto, Syed Hussain, Danna Chan, Denise Dunkley, Nichola Downs, Ellice Marwood, Laura Day, Geoff Saunders, Michelle Light, Amy Whitehead, Deborah Ellis, Naveed Sarwar, Deborah Enting, Alison Birtle, Bernadette Johnson, Robert Huddart, Gareth Griffiths,

<h4>Purpose</h4>Preclinical data indicate that DNA methyltransferase inhibition will circumvent cisplatin resistance in various cancers.<h4>Patient and methods</h4>SPIRE comprised a dose-escalation phase for incurable metastatic solid cancers, followed by a randomized dose expansion phase for neoadjuvant treatment of T2-4a N0 M0 bladder urothelial carcinoma. The primary objective was a recommended phase II ... Read more >>

Clin Cancer Res (Clinical cancer research : an official journal of the American Association for Cancer Research)
[2021, 27(7):1882-1892]

Cited: 0 times

View full text PDF listing >>



Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.

James W F Catto, Kathryn Gordon, Michelle Collinson, Heather Poad, Maureen Twiddy, Mark Johnson, Sunjay Jain, Rohit Chahal, Matt Simms, Mohantha Dooldeniya, Richard Bell, Phillip Koenig, Samantha Conroy, Louise Goodwin, Aidan P Noon, Julie Croft, Julia M Brown, ,

<h4>Purpose</h4>High-grade nonmuscle invasive bladder cancer (HRNMIBC) is a heterogeneous disease. Treatments include intravesical maintenance <i>Bacillus Calmette-Guerin</i> (mBCG) and radical cystectomy (RC). We wanted to understand whether a randomized trial comparing these options was possible.<h4>Materials and methods</h4>We conducted a two-arm, prospective multicenter randomized study to determine the feasibility in <i>Bacillus Calmette-Guerin</i>-naive ... Read more >>

J Clin Oncol (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2021, 39(3):202-214]

Cited: 2 times

View full text PDF listing >>



Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes.

Oliver Reed, Ibrahim Jubber, Jon Griffin, Aidan P Noon, Louise Goodwin, Syed Hussain, Marcus G Cumberbatch, James W F Catto,

<h4>Objectives</h4>Up to 10% of Bladder Cancers may arise following occupational exposure to carcinogens. We hypothesised that different cancer phenotypes reflected different patterns of occupational exposure.<h4>Methods</h4>Consecutive participants, with bladder cancer, self-completed a structured questionnaire detailing employment, tasks, exposures, smoking, lifestyle and family history. Our primary outcome was association between cancer phenotype ... Read more >>

PLoS One (PloS one)
[2020, 15(10):e0239338]

Cited: 2 times

View full text PDF listing >>



Corrigendum to 'Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis' [European Urology Oncology 3 (2020) 306-315].

Sungmin Woo, Valeria Panebianco, Yoshifumi Narumi, Francesco Del Giudice, Valdair F Muglia, Mitsuru Takeuchi, Soleen Ghafoor, Bernard H Bochner, Alvin C Goh, Hedvig Hricak, James W F Catto, Hebert Alberto Vargas,

[This corrects the article PMC7293940.]. ... Read more >>

Eur Urol Oncol (European urology oncology)
[2020, 3(6):811]

Cited: 0 times

View full text PDF listing >>



Systematic Review and Meta-Analysis of Vesical Imaging-Reporting and Data System (VI-RADS) Inter-Observer Reliability: An Added Value for Muscle Invasive Bladder Cancer Detection.

Francesco Del Giudice, Martina Pecoraro, Hebert Alberto Vargas, Stefano Cipollari, Ettore De Berardinis, Marco Bicchetti, Benjamin I Chung, Carlo Catalano, Yoshifumi Narumi, James W F Catto, Valeria Panebianco,

The Vesical Imaging-Reporting and Data System (VI-RADS) has been introduced to provide preoperative bladder cancer staging and has proved to be reliable in assessing the presence of muscle invasion in the pre-TURBT (trans-urethral resection of bladder tumor). We aimed to assess through a systematic review and meta-analysis the inter-reader variability ... Read more >>

Cancers (Basel) (Cancers)
[2020, 12(10):]

Cited: 1 time

View full text PDF listing >>



Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer.

Yüksel Ürün, Syed A Hussain, Ziad Bakouny, Daniel Castellano, Saadettin Kılıçkap, Gilberto Morgan, Rana R Mckay, Kevin Pels, Andrew Schmidt, Deborah B Doroshow, Fábio Schütz, Laurence Albiges, Gilberto Lopes, James W F Catto, Solange Peters, Toni K Choueiri,

<h4>Purpose</h4>To understand readiness measures taken by oncologists to protect patients and health care workers from the novel coronavirus (COVID-19) and how their clinical decision making was influenced by the pandemic.<h4>Methods</h4>An online survey was conducted between March 24 and April 29, 2020.<h4>Results</h4>A total of 343 oncologists from 28 countries participated. The ... Read more >>

JCO Glob Oncol (JCO global oncology)
[2020, 6:1248-1257]

Cited: 11 times

View full text PDF listing >>



Reply to Gianluca Giannarini, Vincenzo Ficarra, and Claudio Valotto's Letter to the Editor re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.06.039.

Stephen B Williams, Ibrahim Jubber, James W F Catto, Siamak Daneshmand,

Eur Urol (European urology)
[2020, 78(5):e190-e191]

Cited: 1 time

View full text PDF listing >>



Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review.

Nathan A Brooks, Andrea Kokorovic, John S McGrath, Wassim Kassouf, Justin W Collins, Peter C Black, James Douglas, Hooman Djaladat, Siamak Daneshmand, James W F Catto, Ashish M Kamat, Stephen B Williams,

<h4>Purpose</h4>Enhanced recovery after surgery (ERAS) protocols have been implemented across a variety of disciplines to improve outcomes. Herein we describe the impact of ERAS on quality of life (QOL) and cost for patients undergoing urologic oncology surgery.<h4>Methods</h4>A systematic literature search using the MEDLINE, Scopus, Clinictrials.gov, and Cochrane Review databases for ... Read more >>

World J Urol (World journal of urology)
[2020, :]

Cited: 5 times

View full text PDF listing >>



Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis.

Stephen B Williams, Marcus G K Cumberbatch, Ashish M Kamat, Ibrahim Jubber, Preston S Kerr, John S McGrath, Hooman Djaladat, Justin W Collins, Vignesh T Packiam, Gary D Steinberg, Eugene Lee, Wassim Kassouf, Peter C Black, Yannick Cerantola, James W F Catto, Siamak Daneshmand,

<h4>Context</h4>Enhanced Recovery After Surgery (ERAS) is a perioperative approach to managing surgical patients. The impact of ERAS on radical cystectomy (RC) outcomes remains understudied.<h4>Objective</h4>To review the literature regarding ERAS protocols and RC outcomes. The primary outcome was hospital length of stay (LOS).<h4>Evidence acquisition</h4>A systematic review of the articles published from ... Read more >>

Eur Urol (European urology)
[2020, 78(5):719-730]

Cited: 6 times

View full text PDF listing >>



The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer.

Sian M Noble, Kirsty Garfield, J Athene Lane, Chris Metcalfe, Michael Davis, Eleanor I Walsh, Richard M Martin, Emma L Turner, Tim J Peters, Joanna C Thorn, Malcolm Mason, Prasad Bollina, James W F Catto, Alan Doherty, Vincent Gnanapragasam, Owen Hughes, Roger Kockelbergh, Howard Kynaston, Alan Paul, Edgar Paez, Derek J Rosario, Edward Rowe, Jon Oxley, John Staffurth, David E Neal, Freddie C Hamdy, Jenny L Donovan,

<h4>Background</h4>There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer.<h4>Methods</h4>The cost-effectiveness of active monitoring, surgery, and radiotherapy was evaluated within the Prostate Testing for Cancer and Treatment (ProtecT) randomised controlled trial from a UK NHS perspective at 10 years' median follow-up. Prostate cancer resource-use collected from ... Read more >>

Br J Cancer (British journal of cancer)
[2020, 123(7):1063-1070]

Cited: 2 times

View full text PDF listing >>



The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.

Karl H Pang, Francis Thomas, Giacomo Novara, Omar S Din, Susan L Morgan, Syed A Hussain, Ibrahim Jubber, Aidan P Noon, James W F Catto, Derek J Rosario,

<h4>Background</h4>The 2002 National Institute for Health and Care Excellence guidance on centralisation of radical cystectomy (RC) coincided with changes in practice: use of neoadjuvant chemotherapy (NAC) and pelvic lymph node dissection (PLND), and RC for high-risk non-muscle-invasive bladder cancer (HR-NMIBC).<h4>Objective</h4>To report the outcomes of RC at a single centre and ... Read more >>

Eur Urol Focus (European urology focus)
[2021, 7(3):554-565]

Cited: 0 times

View full text PDF listing >>



Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature.

Melanie R Hassler, Freddie Bray, James W F Catto, Arthur P Grollman, Arndt Hartmann, Vitaly Margulis, Surena F Matin, Morgan Roupret, John P Sfakianos, Shahrokh F Shariat, Bishoy M Faltas,

<h4>Context</h4>While upper tract urothelial carcinoma (UTUC) share histological appearance with bladder cancer (BC), the former has differences in etiology and clinical phenotype consistent with characteristic molecular alterations.<h4>Objective</h4>To systematically evaluate current genomic sequencing and proteomic data examining molecular alterations in UTUC.<h4>Evidence acquisition</h4>A systematic review using PubMed, Scopus, and Web of Science ... Read more >>

Eur Urol (European urology)
[2020, 78(2):209-220]

Cited: 8 times

View full text PDF listing >>



CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer.

A Hugh Mostafid, Nuria Porta, Joanne Cresswell, Thomas R L Griffiths, John D Kelly, Steven R Penegar, Kim Davenport, John S McGrath, Nicholas Campain, Peter Cooke, Shikohe Masood, Margaret A Knowles, Andrew Feber, Allen Knight, James W F Catto, Rebecca Lewis, Emma Hall,

<h4>Objectives</h4>To evaluate the activity of intravesical mitomycin-C (MMC) to ablate recurrent low-risk non-muscle-invasive bladder cancer (NMIBC) and assess whether it may enable patients to avoid surgical intervention for treatment of recurrence.<h4>Patients and methods</h4>CALIBER is a phase II feasibility study. Participants were randomized (2:1) to treatment with four once-weekly MMC 40-mg ... Read more >>

BJU Int (BJU international)
[2020, 125(6):817-826]

Cited: 0 times

View full text PDF listing >>



Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

Sungmin Woo, Valeria Panebianco, Yoshifumi Narumi, Francesco Del Giudice, Valdair F Muglia, Mitsuru Takeuchi, Soleen Ghafoor, Bernard H Bochner, Alvin C Goh, Hedvig Hricak, James W F Catto, Hebert Alberto Vargas,

<h4>Context</h4>A noninvasive multiparametric magnetic resonance imaging (MRI)-based scoring system for predicting muscle-invasive bladder cancer (MIBC), the "Vesical Imaging Reporting and Data System" (VI-RADS), was recently developed by an international multidisciplinary panel. Since then, a few studies evaluating the value of VI-RADS for predicting MIBC have been published.<h4>Objective</h4>To review the diagnostic ... Read more >>

Eur Urol Oncol (European urology oncology)
[2020, 3(3):306-315]

Cited: 7 times

View full text PDF listing >>



Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Niranjan J Sathianathen, Altan Omer, Eli Harriss, Lucy Davies, Veeru Kasivisvanathan, Shonit Punwani, Caroline M Moore, Christof Kastner, Tristan Barrett, Roderick Cn Van Den Bergh, Ben A Eddy, Fergus Gleeson, Ruth Macpherson, Richard J Bryant, James W F Catto, Declan G Murphy, Freddie C Hamdy, Hashim U Ahmed, Alastair D Lamb,

<h4>Context</h4>Prebiopsy multiparametric magnetic resonance imaging (mpMRI) is increasingly used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI is used by some clinicians to aid in decision making about whether or not to proceed to biopsy.<h4>Objective</h4>We aim to perform a contemporary systematic review that reflects the latest ... Read more >>

Eur Urol (European urology)
[2020, 78(3):402-414]

Cited: 4 times

View full text PDF listing >>



Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.

Christopher J D Wallis, Giacomo Novara, Laura Marandino, Axel Bex, Ashish M Kamat, R Jeffrey Karnes, Todd M Morgan, Nicolas Mottet, Silke Gillessen, Alberto Bossi, Morgan Roupret, Thomas Powles, Andrea Necchi, James W F Catto, Zachary Klaassen,

<h4>Context</h4>The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the treatment of many urologic cancers.<h4>Objective</h4>To provide a contemporary picture of the risks from delayed treatment for urologic cancers to assist with triage.<h4>Evidence acquisition</h4>A collaborative review using literature published as of April 2, 2020.<h4>Evidence synthesis</h4>Patients with low-grade non-muscle-invasive bladder ... Read more >>

Eur Urol (European urology)
[2020, 78(1):29-42]

Cited: 33 times

View full text PDF listing >>



Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic.

Kristian D Stensland, Todd M Morgan, Alireza Moinzadeh, Cheryl T Lee, Alberto Briganti, James W F Catto, David Canes,

We present a suggested list of urologic surgeries that should be prioritized if COVID-19 surges warrant cancellation of elective surgeries to free up health care resources. The recommendations should be tailored to locally available resources and situations and can be used as a framework for other specialties. ... Read more >>

Eur Urol (European urology)
[2020, 77(6):663-666]

Cited: 103 times

View full text PDF listing >>



The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"?

Benjamin Pradère, Guillaume Ploussard, James W F Catto, Morgan Rouprêt, Vincent Misrai,

Eur Urol (European urology)
[2020, 78(2):134-135]

Cited: 3 times

View full text PDF listing >>



Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence.

Pramit Khetrapal, Samantha Conroy, John D Kelly, James W F Catto,

<h4>Purpose of review</h4>Radical cystectomy is the definitive surgical treatment for aggressive bladder cancer. The robotic platform offers a new approach to radical cystectomy, but the benefits are unclear. This review examines the latest evidence, with a particular focus on developments in the last two years.<h4>Recent findings</h4>Prospective evaluations of open (ORC) ... Read more >>

Curr Opin Urol (Current opinion in urology)
[2020, 30(3):400-406]

Cited: 0 times

View full text PDF listing >>



VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic.

Valeria Panebianco, Francesco Del Giudice, Costantino Leonardo, Alessandro Sciarra, Carlo Catalano, James W F Catto,

Eur Urol (European urology)
[2020, 78(1):e18-e20]

Cited: 2 times

View full text PDF listing >>



Advertisement

Disclaimer
1.324 s